Calvin Sandra's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Feb 12, 2025
- Accession no.
- 0001415889-25-003822
- Filed
- Feb 12, 2025
- Trade date
- Feb 11, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.36M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Calvin SandraCIK 0001882909 | Officer (SVP, CHIEF ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $16.23 | +$162,300 | 73,654 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −10,000 | $25.00 | −$250,000 | 63,654 | Direct | |
| Feb 11, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $17.44 | +$174,400 | 73,654 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −10,000 | $25.00 | −$250,000 | 63,654 | Direct | |
| Feb 11, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $17.96 | +$179,600 | 73,654 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −10,000 | $25.00 | −$250,000 | 63,654 | Direct | |
| Feb 11, 2025 | Common Stock | MOption exerciseAcquired | +15,000 | $15.46 | +$231,900 | 78,654 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −15,000 | $25.00 | −$375,000 | 63,654 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −9,244 | $25.00 | −$231,100 | 54,410 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Feb 11, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Feb 11, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Feb 11, 2025 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.